Since increased cellular levels of reactive oxygen species (ROS), as evidenced by the increased superoxide generation (Fig 5), regulate gene expression, we speculate that hyperoxaluria-induced NaDC-1 upregulation may be mediated by ROS. The gene discussed is SLC13A2; the disease is Hyperoxaluria.